BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,195,467 | +94.6% | 529,456 | +183.7% | 0.05% | +126.1% |
| Q1 2022 | $11,921,000 | -88.3% | 186,600 | -80.4% | 0.02% | -87.8% |
| Q4 2021 | $101,827,000 | +3553.6% | 950,682 | +3407.4% | 0.19% | +1466.7% |
| Q3 2021 | $2,787,000 | -18.9% | 27,105 | -30.7% | 0.01% | -25.0% |
| Q2 2021 | $3,438,000 | +742.6% | 39,086 | +973.2% | 0.02% | +700.0% |
| Q4 2020 | $408,000 | -98.3% | 3,642 | -98.6% | 0.00% | -98.7% |
| Q3 2020 | $24,186,000 | +1255.7% | 260,902 | +1041.3% | 0.16% | +1191.7% |
| Q2 2020 | $1,784,000 | -85.5% | 22,860 | -89.2% | 0.01% | -90.2% |
| Q1 2020 | $12,340,000 | +2131.5% | 211,006 | +2956.7% | 0.12% | +2975.0% |
| Q4 2019 | $553,000 | +18.7% | 6,903 | -20.1% | 0.00% | -20.0% |
| Q4 2018 | $466,000 | -98.0% | 8,635 | -97.1% | 0.01% | -94.9% |
| Q3 2018 | $23,158,000 | +2624.5% | 296,668 | +879.0% | 0.10% | +1550.0% |
| Q4 2016 | $850,000 | – | 30,302 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |